Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Patient safety research: an overview of the global evidence.

Jha AK, Prasopa-Plaizier N, Larizgoitia I, Bates DW; Research Priority Setting Working Group of the WHO World Alliance for Patient Safety.

Qual Saf Health Care. 2010 Feb;19(1):42-7. doi: 10.1136/qshc.2008.029165.

PMID:
20172882
2.

Adverse drug event rates in six community hospitals and the potential impact of computerized physician order entry for prevention.

Hug BL, Witkowski DJ, Sox CM, Keohane CA, Seger DL, Yoon C, Matheny ME, Bates DW.

J Gen Intern Med. 2010 Jan;25(1):31-8. doi: 10.1007/s11606-009-1141-3. Epub 2009 Nov 6.

3.

Global priorities for patient safety research.

Bates DW, Larizgoitia I, Prasopa-Plaizier N, Jha AK; Research Priority Setting Working Group of the WHO World Alliance for Patient Safety.

BMJ. 2009 May 14;338:b1775. doi: 10.1136/bmj.b1775. No abstract available.

PMID:
19443552
4.

The Japanese healthcare system.

Nomura H, Nakayama T.

BMJ. 2005 Sep 24;331(7518):648-9. No abstract available.

5.

Hospitalwide adverse drug events before and after limiting weekly work hours of medical residents to 80.

Mycyk MB, McDaniel MR, Fotis MA, Regalado J.

Am J Health Syst Pharm. 2005 Aug 1;62(15):1592-5.

PMID:
16030369
6.

Application of U.S. guidelines in other countries: aspirin for the primary prevention of cardiovascular events in Japan.

Morimoto T, Fukui T, Lee TH, Matsui K.

Am J Med. 2004 Oct 1;117(7):459-68. Review.

PMID:
15464702
7.

Adverse drug events and medication errors: detection and classification methods.

Morimoto T, Gandhi TK, Seger AC, Hsieh TC, Bates DW.

Qual Saf Health Care. 2004 Aug;13(4):306-14.

8.

Improving safety with information technology.

Bates DW, Gawande AA.

N Engl J Med. 2003 Jun 19;348(25):2526-34. No abstract available.

9.

Adverse drug events in ambulatory care.

Gandhi TK, Weingart SN, Borus J, Seger AC, Peterson J, Burdick E, Seger DL, Shu K, Federico F, Leape LL, Bates DW.

N Engl J Med. 2003 Apr 17;348(16):1556-64.

10.

Medication errors and adverse drug events in pediatric inpatients.

Kaushal R, Bates DW, Landrigan C, McKenna KJ, Clapp MD, Federico F, Goldmann DA.

JAMA. 2001 Apr 25;285(16):2114-20.

PMID:
11311101
11.

Using information technology to reduce rates of medication errors in hospitals.

Bates DW.

BMJ. 2000 Mar 18;320(7237):788-91. No abstract available.

12.

Japanese hospitals--culture and competition: a study of ten hospitals.

Anbäcken O.

Int J Health Plann Manage. 1994 Jan-Mar;9(1):87-101.

PMID:
10137135
13.
14.

Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies.

Lazarou J, Pomeranz BH, Corey PN.

JAMA. 1998 Apr 15;279(15):1200-5.

PMID:
9555760
15.

The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group.

Bates DW, Spell N, Cullen DJ, Burdick E, Laird N, Petersen LA, Small SD, Sweitzer BJ, Leape LL.

JAMA. 1997 Jan 22-29;277(4):307-11.

PMID:
9002493
16.

Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group.

Bates DW, Cullen DJ, Laird N, Petersen LA, Small SD, Servi D, Laffel G, Sweitzer BJ, Shea BF, Hallisey R, et al.

JAMA. 1995 Jul 5;274(1):29-34.

PMID:
7791255
17.

Adverse drug reactions during hospitalization.

Ogilvie RI, Ruedy J.

Can Med Assoc J. 1967 Dec 9;97(24):1450-7. No abstract available.

18.

Intensive hospital monitoring of adverse reactions to drugs.

Hurwitz N, Wade OL.

Br Med J. 1969 Mar 1;1(5643):531-6.

19.

Adverse drug reactions in a general hospital.

Smidt NA, McQueen EG.

N Z Med J. 1973 Jul 11;78(494):39. No abstract available.

PMID:
4516951
20.

The nature of adverse events in hospitalized patients. Results of the Harvard Medical Practice Study II.

Leape LL, Brennan TA, Laird N, Lawthers AG, Localio AR, Barnes BA, Hebert L, Newhouse JP, Weiler PC, Hiatt H.

N Engl J Med. 1991 Feb 7;324(6):377-84.

Supplemental Content

Support Center